TLR7 and neoplasm: NPs loaded with vR848 (an agonist of the toll-like receptors TLR7 and TLR8) were delivered to tumor tissues in an immunocompetent mouse model of colorectal cancer (MC38) in C57BL/6 mice and promoted the M1 phenotype of TAMs as well as suppressed carcinogenesis [359].